Skip to main content

Navigation group

Type at least 3 characters
485 articles

Articles

Original Research

Published on 22 Aug 2022

Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice

in Translational Medicine

  • Mònica SabatĂ© Gallego
  • EulĂ lia PĂ©rez Esquirol
  • NĂşria Garcia DoladĂ©
  • Xavier Vidal Guitart
  • Maria-Josep Carreras Soler
  • Anna Farriols DanĂ©s
  • Enriqueta Felip
  • Irene Braña
  • Joan Carles Galceran
  • Rafael Morales Barrera
Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice
Frontiers in Medicine
doi 10.3389/fmed.2022.891179
  • 3,052 views
  • 2 citations

Study Protocol

Published on 11 Aug 2022

Rationale and design of the prevention of paclitaxel-related neurological side effects with lithium trial – Protocol of a multicenter, randomized, double-blind, placebo- controlled proof-of-concept phase-2 clinical trial

in Translational Medicine

  • Petra Huehnchen
  • Nikola Bangemann
  • Sandra Lischewski
  • Stefanie Märschenz
  • Friedemann Paul
  • Tanja Schmitz-HĂĽbsch
  • Jens-Uwe Blohmer
  • Cornelia Eberhardt
  • Geraldine Rauch
  • Agnes Flöel
Rationale and design of the prevention of paclitaxel-related neurological side effects with lithium trial – Protocol of a multicenter, randomized, double-blind, placebo- controlled proof-of-concept phase-2 clinical trial
Frontiers in Medicine
doi 10.3389/fmed.2022.967964
  • 4,221 views
  • 5 citations